KYMR

Kymera Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

92

Buys

12

Sells

47

Largest Trade

N/A

Insiders

14

Institutional Funds

193

Inst. Value

$1M+

Activist Filings

42

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Booth BruceDirectorSELL$500K+27K$35.27Jun 14, 2024
Horobin JoannaDirectorEXERCISE$15K–$50K9K$2.08Jun 7, 2024
Horobin JoannaDirectorSELL$100K–$500K9K$32.99Jun 7, 2024
Chadwick Jeremy GCOOSELL$50K–$100K3K$34.99May 23, 2024
Gollob JaredChief Medical Offi…GRANTN/A24KMar 4, 2024
Gollob JaredChief Medical Offi…SELL$100K–$500K3K$41.86Mar 4, 2024
Jacobs Bruce N.CFOGRANTN/A31KMar 4, 2024
Jacobs Bruce N.CFOSELL$100K–$500K4K$41.86Mar 4, 2024
Gollob JaredChief Medical Offi…SELL$15K–$50K400$45.00Feb 29, 2024
Gollob JaredChief Medical Offi…EXERCISE<$1K400$2.08Feb 29, 2024
Albers Jeffrey W.DirectorEXERCISE$50K–$100K5K$10.34Feb 21, 2024
Albers Jeffrey W.DirectorSELL$100K–$500K5K$39.05Feb 21, 2024
Gollob JaredChief Medical Offi…SELL$1M+46K$35.50Feb 10, 2024
Gollob JaredChief Medical Offi…EXERCISE$50K–$100K46K$2.08Feb 10, 2024
Albers Jeffrey W.DirectorSELL$100K–$500K10K$30.05Jan 24, 2024
Albers Jeffrey W.DirectorEXERCISE$100K–$500K10K$10.34Jan 24, 2024
BVF PARTNERS L P/ILDirectorBUY$1M+414K$12.80Nov 6, 2023
Caughey ElaineChief Business Off…SELL$15K–$50K714$31.00Mar 3, 2023
Caughey ElaineChief Business Off…GRANTN/A11KMar 3, 2023
Gollob JaredChief Medical Offi…SELL$15K–$50K1K$31.00Mar 3, 2023
Gollob JaredChief Medical Offi…GRANTN/A19KMar 3, 2023
Jacobs Bruce N.CFOGRANTN/A24KMar 3, 2023
Jacobs Bruce N.CFOSELL$15K–$50K1K$31.00Mar 3, 2023
BVF PARTNERS L P/ILDirectorBUY$1M+41K$30.51Jan 13, 2023
Booth BruceDirectorSELL$1M+126K$30.22Jan 13, 2023
Atlas Venture Fund X, L.P.10% OwnerSELL$1M+126K$30.22Jan 13, 2023
Booth BruceDirectorSELL$1M+382K$31.36Dec 16, 2022
Atlas Venture Fund X, L.P.10% OwnerSELL$1M+382K$31.36Dec 16, 2022
Booth BruceDirectorSELL$1M+220K$30.01Nov 4, 2022
Atlas Venture Fund X, L.P.10% OwnerSELL$1M+220K$30.01Nov 4, 2022
Booth BruceDirectorSELL$1M+289K$30.26Nov 1, 2022
Atlas Venture Fund X, L.P.10% OwnerSELL$1M+289K$30.26Nov 1, 2022
BVF PARTNERS L P/ILDirectorBUY$1M+546K$26.00Aug 23, 2022
BVF PARTNERS L P/ILDirectorBUY$1M+289K$14.34May 31, 2022
BVF PARTNERS L P/ILDirectorBUY$100K–$500K10K$14.00May 25, 2022
BVF PARTNERS L P/ILDirectorBUY$1M+250K$19.46May 9, 2022
BVF PARTNERS L P/ILDirectorBUY$1M+130K$38.96Feb 1, 2022
BVF PARTNERS L P/ILDirectorBUY$1M+273K$37.76Jan 27, 2022
Jacobs Bruce N.CFOSELL$500K+15K$51.85Jan 14, 2022
Jacobs Bruce N.CFOEXERCISE$15K–$50K15K$2.08Jan 14, 2022
Mainolfi NelloCEOSELL$1M+48K$53.31Jan 13, 2022
Mainolfi NelloCEOEXERCISE$50K–$100K48K$2.08Jan 13, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Wellington Management Group LLP

SC 13G/A · Feb 10, 2026

5.5%

4.4M shares

FMR LLC

SC 13G/A · Jan 8, 2026

11.2%

8.9M shares

BIOTECHNOLOGY VALUE FUND L P

SC 13D/A · Dec 15, 2025

4.4%

3.6M shares

Baker Bros. Advisors LP

SC 13D/A · Dec 11, 2025

10.9%

8.7M shares

T. Rowe Price Associates, Inc.

SC 13G/A · Nov 14, 2025

7.1%

5.1M shares

FMR LLC

SC 13G/A · Nov 5, 2025

8.2%

5.9M shares

Wellington Management Group LLP

SC 13G/A · Aug 12, 2025

7.7%

5.4M shares

BlackRock, Inc.

SC 13G/A · Jul 18, 2025

5.4%

3.8M shares

Baker Bros. Advisors LP

SC 13D/A · Jul 1, 2025

9.5%

6.7M shares

Wellington Management Group LLP

SC 13G/A · May 12, 2025

9.2%

6.0M shares

FMR LLC

SC 13G/A · May 12, 2025

6.8%

4.4M shares

The Vanguard Group

SC 13G/A · Apr 30, 2025

8.1%

5.2M shares

Wellington Management Group LLP

SC 13G/A · Feb 10, 2025

8.2%

5.3M shares

Atlas Venture Fund X, L.P.

SC 13G/A · Nov 14, 2024

6.4%

4.2M shares

10.3%

6.6M shares

Avoro Capital Advisors LLC

SC 13G/A · Nov 14, 2024

10.0%

7.8M shares

FMR LLC

SC 13G · Nov 12, 2024

7.9%

5.1M shares

Wellington Management Group LLP

SC 13G/A · Nov 8, 2024

7.2%

4.6M shares

Baker Bros. Advisors LP

SC 13D/A · Aug 22, 2024

9.3%

6.0M shares

Baker Bros. Advisors LP

SC 13D · Apr 1, 2024

9.8%

6.0M shares

Avoro Capital Advisors LLC

SC 13G/A · Feb 14, 2024

6.8%

3.8M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

6.7%

4.0M shares

10.1%

6.0M shares

9.6%

5.3M shares

BlackRock, Inc.

SC 13G/A · Jan 29, 2024

6.4%

3.6M shares

Baker Bros. Advisors LP

SC 13G/A · Jan 10, 2024

10.8%

6.0M shares

BIOTECHNOLOGY VALUE FUND, L.P.

SC 13D/A · Jan 9, 2024

5.5%

3.2M shares

0.0%

0 shares

Atlas Venture Fund X, L.P.

SC 13G/A · Feb 14, 2023

9.2%

5.1M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2023

4.9%

2.7M shares

Baker Bros. Advisors LP

SC 13G · Feb 14, 2023

5.2%

2.9M shares

8.0%

4.4M shares

Avoro Capital Advisors LLC

SC 13G · Feb 14, 2023

7.0%

3.9M shares

BlackRock, Inc.

SC 13G/A · Feb 1, 2023

6.1%

3.3M shares

BIOTECHNOLOGY VALUE FUND, L.P.

SC 13D/A · Aug 23, 2022

4.5%

2.5M shares

10.1%

5.2M shares

BIOTECHNOLOGY VALUE FUND, L.P.

SC 13D/A · Jun 1, 2022

4.3%

2.2M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2022

5.0%

2.6M shares

6.9%

3.6M shares

Atlas Venture Fund X, L.P.

SC 13G/A · Feb 11, 2022

11.2%

5.8M shares

BIOTECHNOLOGY VALUE FUND, L.P.

SC 13D/A · Jan 31, 2022

3.7%

1.9M shares

View on Google Finance →